Because iNOS functions not only as a key biomarker of macrophage activation but also as a regulatory hub in immune signaling, it has been recognized as a promising therapeutic target in a range of pathological conditions—including chronic inflammation, autoimmune disease, atherosclerosis, neurodegeneration, and cancer [16]. The gene discussed is NOS2; the disease is cancer.